References
1. Brunner PM, Silverberg JI, Guttman-Yassky E, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder.J Invest Dermatol . 2017;137(1):18-25.
2. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from isaac phase three. J Allergy Clinl Immunol . 2009;124(6):1251-1258.
3. Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey.Allergy . 2018;73(6):1284-1293.
4. Abuabara K, Hoffstad O, Troxel AB, Gelfand JM, McCulloch CE, Margolis DJ. Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study. J Allergy Clin Immunol . 2018;141(2):778-780.
5. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM. The prevalence of atopic dermatitis beyond childhood: A systematic review and meta-analysis of longitudinal studies. Allergy . 2018;73(3):696-704.
6. Silverberg JI, Barbarot S, Gadkari A, et al. Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol . 2021;126(4):417-428.
7. Vakharia PP, Silverberg JI. Adult-onset atopic dermatitis: Characteristics and management. Am J Clin Dermatol . 2019;20(6):771-779.
8. Sendrasoa FA, Ranaivo IM, Razanakoto NH, et al. Epidemiology and associated factors of atopic dermatitis in malagasy children.Allergy Asthma Clinl Immunol . 2020;16(1):4.
9. Kiiski V, Salava A, Susitaival P, Barnhill S, Remitz A, Heliovaara M. Atopic dermatitis in adults: A population-based study in finland.Int J Dermatol . 2022;61(3):324-330.
10. Liu W, Cai J, Sun C, Zou Z, Zhang J, Huang C. Time-trends for eczema prevalences among children and adults from 1985 to 2015 in china: A systematic review. BMC Public Health . 2022;22(1):1294.
11. Cheng J, Wu JJ, Han G. Epidemiology and characterization of atopic dermatitis in east asian populations: A systematic review.Dermatol Ther . 2021;11(3):707-717.
12. Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in chinese children aged 1-7 ys. Sci Rep . 2016;6:29751.
13. Dong W-l, An J, Yu M, et al. The prevalence and year lived with disability of atopic dermatitis in china: Findings from the global burden of disease study 2019. World Allergy Organ J . 2021;14(11):100604.
14. Abuabara K, Ye M, McCulloch CE, et al. Clinical onset of atopic eczema: Results from 2 nationally representative british birth cohorts followed through midlife. J Allergy Clin Immunol . 2019;144(3):710-719.
15. Williamson S, Merritt J, De Benedetto A. Atopic dermatitis in the elderly: A review of clinical and pathophysiological hallmarks. Br J Dermatol . 2020;182(1):47-54.
16. de Bruin-Weller M, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: A cross-sectional study in europe and canada. J Eur Acad Dermatol Venereol . 2020;34(5):1026-1036.
17. Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in america study: A cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the us adult population. J Invest Dermatol . 2019;139(3):583-590.
18. Engebretsen KA, Johansen JD, Kezic S, Linneberg A, Thyssen JP. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol . 2016;30(2):223-249.
19. Campbell BC, Gilding EK, Timbrell V, et al. Total transcriptome, proteome, and allergome of johnson grass pollen, which is important for allergic rhinitis in subtropical regions. J Allergy Clin Immunol . 2015;135(1):133-142.
20. Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96-103.
21. Schneider L, Hanifin J, Boguniewicz M, et al. Study of the atopic march: Development of atopic comorbidities. Pediatr Dermatol . 2016;33(4):388-398.
22. Silverberg JI, Gelfand JM, Margolis DJ, et al. Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in us adults. Ann Allergy Asthma Immunol . 2018;121(5):604-612.
23. Silverberg JI, Becker L, Kwasny M, Menter A, Cordoro KM, Paller AS. Central obesity and high blood pressure in pediatric patients with atopic dermatitis. JAMA Dermatol . 2015;151(2):144-152.
24. Ben Abdallah H, Vestergaard C. Atopic dermatitis, hypertension and cardiovascular disease. Br J Dermatol . 2022;186(2):203-204.
25. Ruethers T, Taki AC, Johnston EB, et al. Seafood allergy: A comprehensive review of fish and shellfish allergens. Mol Immunol . 2018;100:28-57.
26. Kwon JA, Park E-C, Lee M, Yoo K-B, Park S. Does stress increase the risk of atopic dermatitis in adolescents? Results of the korea youth risk behavior web-based survey (KYRBWS-VI). PLOS ONE . 2013;8(8):e67890.
27. Buske-Kirschbaum A, Gierens A, Höllig H, Hellhammer DH. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J Neuroimmunol . 2002;129(1-2):161-167.
28. Wright RJ, Finn P, Contreras JP, et al. Chronic caregiver stress and ige expression, allergen-induced proliferation, and cytokine profiles in a birth cohort predisposed to atopy. J Allergy Clin Immunol . 2004;113(6):1051-1057.
29. Buske-Kirschbaum A, Geiben A, Höllig H, Morschhäuser E, Hellhammer D. Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab . 2002;87(9):4245-4251.
30. Chang Y-S, Chiang B-L. Sleep disorders and atopic dermatitis: A 2-way street? J Allergy Clin Immunol . 2018;142(4):1033-1040.
31. Davis DMR, Drucker AM, Alikhan A, et al. American academy of dermatology guidelines: Awareness of comorbidities associated with atopic dermatitis in adults. J Am Acad Dermatol . 2022;86(6):1335-1336.
32. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based european guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: Part i. J Eur Acad Dermatol Venereol . 2018;32(5):657-682.
33. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol . 2014;71(1):116-132.
34. Lee JH, Kim JE, Park GH, et al. Consensus update for systemic treatment of atopic dermatitis. Ann Dermatol . 2021;33(6):497-514.
35. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol . 2014;71(2):327-349.
36. La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy . 1994;73(2):117-122.
37. Henz BM, Metzenauer P, O’Keefe E, Zuberbier T. Differential effects of new-generation h1-receptor antagonists in pruritic dermatoses.Allergy . 1998;53(2):180-183.
38. Daley-Yates PT, Richards DH. Relationship between systemic corticosteroid exposure and growth velocity: Development and validation of a pharmacokinetic/pharmacodynamic model. Clin Ther . 2004;26(11):1905-1919.
39. Wise J. Nice recommends three more treatments for atopic dermatitis.BMJ . 2022;377:o1618.
40. Chun PIF, Lehman H. Current and future monoclonal antibodies in the treatment of atopic dermatitis. Clin Rev Allergy Immunol . 2020;59(2):208-219.
41. Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis.Ann Allergy Asthma Immunol . 2021;126(1):21-31.
42. Chovatiya R, Paller AS. Jak inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol . 2021;148(4):927-940.
43. Tan WP, Suresh S, Tey HL, Chiam LY, Goon AT. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis.Clin Exp Dermatol . 2010;35(4):e109-112.
44. Korting HC, Schöllmann C, Cholcha W, Wolff L. Efficacy and tolerability of pale sulfonated shale oil cream 4% in the treatment of mild to moderate atopic eczema in children: A multicentre, randomized vehicle-controlled trial. J Eur Acad Dermatol Venereol . 2010;24(10):1176-1182.